{"id":"W4409786336","doi":"10.70962/cis2025abstract.216","title":"Safety and Tolerability of a New Intravenous Immunoglobulin (IVIg) 10% (KIg10) in Primary Immunodeficiency (PI) Adult Patients","year":2025,"lang":"en","type":"article","venue":"Journal of Human Immunity","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Tolerability; Primary immunodeficiency; Medicine; Antibody; Immunodeficiency; Pi; Immunology; Internal medicine; Adverse effect; Chemistry; Immune system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001090576,0.0002607256,0.0004747597,0.00009419411,0.0001370418,0.0003849543,0.0001542232,0.0002920729,0.0007947384],"category_scores_gemma":[0.0008695771,0.00009278159,0.0003607326,0.0001189864,0.0002137123,0.0001730052,0.0001214167,0.0005066599,0.000184559],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002562159,"about_ca_system_score_gemma":0.0003093716,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000356536,"about_ca_topic_score_gemma":0.0004601841,"domain_scores_codex":[0.9996637,0.0001774422,0.00002627204,0.00004344012,0.00005098357,0.00003821451],"domain_scores_gemma":[0.9993936,0.0001863631,0.0002348365,0.00002143747,0.00003927395,0.0001245263],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2286813,0.01063624,0.2690915,0.001373894,0.0009582264,0.00106642,0.0005242981,0.002778867,0.08150563,0.0001997792,0.003179736,0.4000042],"study_design_scores_gemma":[0.02224069,0.6005554,0.3548227,0.0001374859,0.0006820735,0.002386855,0.0001906625,0.002289178,0.011522,0.0001022962,0.005039389,0.00003116056],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997265,0.001893432,0.000146784,0.00007097855,0.00001144916,0.0000772749,0.0001230896,0.0000121283,0.0003999064],"genre_scores_gemma":[0.9987608,0.0004838775,0.0001984758,0.0001462281,0.0000254094,0.00005473785,0.0001719969,0.000001431817,0.0001570468],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001090576,"threshold_uncertainty_score":0.005767584,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006076058023916557,"score_gpt":0.2313200887357696,"score_spread":0.225244030711853,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}